Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection

  • Mehrabi Z
  • Salimi M
  • Niknam K
  • et al.
N/ACitations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Mucormycosis is a rare and invasive fungal infection, affecting almost exclusively immunocompromised individuals. Immunosuppressive effects of corticosteroids which are widely prescribed in COVID-19 patients might be a predisposing factor for opportunistic infections even though the other factors should also be considered. Case Presentation. A middle-aged man without any significant past medical history was admitted to the hospital due to a severe COVID-19 infection. He received a high dose of corticosteroids as a part of the treatment. Five days after discharge, he presents with a headache and fever. Eventually, orbital mucormycosis was diagnosed for him and he was treated with antifungal medications. Conclusion. Opportunistic infections should be considered during the current pandemic of COVID-19, during which corticosteroids are widely prescribed.

Cite

CITATION STYLE

APA

Mehrabi, Z., Salimi, M., Niknam, K., Mohammadi, F., Mamaghani, H. J., Sasani, M. R., … Erfani, Z. (2021). Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection. Case Reports in Ophthalmological Medicine, 2021, 1–7. https://doi.org/10.1155/2021/9745701

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free